Identification and quantification of conjugated peptides in antibody drug conjugates by mass spectrometry

US11802879B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11802879-B2
Application numberUS-201716080903-A
CountryUS
Kind codeB2
Filing dateMar 2, 2017
Priority dateMar 2, 2016
Publication dateOct 31, 2023
Grant dateOct 31, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to a streamlined, complete workflow for the qualitative and the quantitative analysis of conjugated peptides from antibody-drug conjugate (ADC) compounds.

First claim

Opening claim text (preview).

We claim: 1. A method for analyzing site occupancy ratios in antibody-drug conjugates, said method comprising: (i) providing a sample comprising an antibody-drug conjugate compound; (ii) exposing the sample to de-salting; (iii) exposing the sample to multienzyme digestion to form a digested peptide mixture, wherein the digested peptide mixture comprises conjugated peptide and unconjugated peptide; (iv) ionizing the sample to form radical ion fragments; (v) detecting the mass-to-charge ratios associated with the radical ion fragments; (vi) analyzing the mass-to-charge ratios of the radical ion fragments; and (vii) quantifying the site occupancy ratio in the sample by determining the ratio of conjugated peptide to conjugated peptide and unconjugated peptide, thereby analyzing site occupancy ratios in antibody-drug conjugates. 2. The method of claim 1 , further comprising identifying the conjugated peptide and unconjugated peptide in the sample. 3. The method of claim 1 , further comprising selecting two separate groups of mass-to-charge ratios of the radical ion fragments. 4. The method of claim 3 , wherein the first group of mass-to-charge ratios is associated with the radical ion fragments of the conjugated peptide. 5. The method of claim 3 , wherein the second group of mass-to-charge ratios is associated with the radical ion fragments of the unconjugated peptide. 6. The method of claim 3 , wherein the selection of the two separate groups of mass-to-charge ratios is based on known ion fragmentation patterns. 7. The method of claim 6 , wherein the known ion fragmentation patterns are stored in a library. 8. The method of claim 1 , wherein the multienzyme digestion comprises a first enzyme and a second enzyme. 9. The method of claim 8 , wherein the first enzyme is trypsin/Lys C. 10. The method of claim 9 , wherein the ratio of the trypsin/Lys C to sample is about 1:25 (w/w). 11. The method of claim 8 , wherein the second enzyme is Asp N. 12. The method of claim 11 , wherein the ratio of the Asp N to sample is about 1:100 (w/w).

Assignees

Inventors

Classifications

  • Methods of protein analysis involving mass spectrometry · CPC title

  • Mass spectrometers {(mass spectrometers per se H01J49/00)} · CPC title

  • interfaced to liquid or supercritical fluid chromatograph (interfaces in general for introducing or extracting samples to be analysed with specially adapted mass spectrometer, see H01J49/04) · CPC title

  • Liquid chromatography · CPC title

  • Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11802879B2 cover?
The present disclosure relates to a streamlined, complete workflow for the qualitative and the quantitative analysis of conjugated peptides from antibody-drug conjugate (ADC) compounds.
Who is the assignee on this patent?
Waters Technologies Corp
What technology area does this patent fall under?
Primary CPC classification G01N33/6848. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).